Nanoform wins CPhI Excellence in Pharma Award for Formulation

The award recognises proprietary CESS nanonisation technology

picture of

Breaking News

Mesa Labs acquires Gyros Protein Technologies

The US-based quality control instrument supplier has acquired the Swedish protein synthesis solutions provider to begin ...

Cryoport joins Lonza vein-to-vein delivery network

Partnership in cell and gene therapy to provide global and fully integrated delivery solutions from manufacturing to ...

Cesca Therapeutics changes name to match new focus

The newly named ThermoGenesis has moved from automated cell separation and cryostorage technologies into cell ...

CPhI Annual Report foresees massive shortfalls in ATP production and bio capacity growth in China

A shortage of qualified personnel may be a drag factor in cell and gene therapies yet in China, 100,00L of capacity ...

Synthetic biology company moves to Cambridge business park in the UK

UK-based gene synthesis specialist Evonetix is developing a desktop DNA synthesis platform based on a proprietary ...

CPhI releases concluding report on trends in biologics

Dawn Ecker and Emil Ciurczak discuss regional growth, addressing new toxic by-products, contracting opportunities, and ...

Medical cannabis made in Italy

Dr Fabio Di Francesco, a compounding pharmacist based in Rome, describes how cannabis is used in medicinal formulations ...

CPhI Worldwide reveals finalists for 2019 Awards

The categories are API Development, formulation, manufacturing technology & equipment, bioprocessing, analysis & ...

Sanofi opens its first digitally enabled continuous manufacturing facility

The biologics manufacturing facility in Framingham, Massachusetts, uses paperless and data-driven manufacturing ...

Rapid, automated at-line antibody titre measurements advance biopharmaceutical production

Biotherapeutic production relies on robust cell lines with reproducible growth, titre and quality, so determining the ...

Continuous bioprocessing: Can your tubing handle the pressure?

Extra strain is on pharmaceutical equipment as a result of the simultaneous rise of single-use components and ...

New enantioselective desymmetrisation strategy uses recombinant pig liver esterases

Enzymicals has established a new compound from the development of an efficient biocatalytic sequential multistep one- ...

Contract win sees Lonza develop and manufacture gene therapies for Prevail

New York-based Prevail Therapeutics has chosen the Swiss CDMO for GMP manufacturing of the AAV9-based gene therapy for ...

Janssen Sciences builds Irish biomanufacturing facility

The Ringaskiddy, Co. Cork site’s production footprint has been expanded by 19,100 sqm, creating 200 new full-time jobs